The price of Oscar Health Inc (NYSE:OSCR) shares last traded on Wall Street rose 30.22% to $17.02.
OSCR stock price is now 26.60% away from the 50-day moving average and 7.06% away from the 200-day moving average. The market capitalization of the company currently stands at $4.33B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $20 to $16, Wells Fargo Downgraded its rating from Overweight to Equal Weight for Oscar Health Inc (NYSE: OSCR). On December 10, 2024, Jefferies recently initiated its ‘Underperform’ rating on the stock quoting a target price of $12, while ‘BofA Securities’ rates the stock as ‘Underperform’
In other news, ALESSANDREA QUANE, Former Officer bought 34,199 shares of the company’s stock on May 07 ’25. The stock was bought for $570,487 at an average price of $16.68. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 10 ’25, Former Officer ALESSANDREA QUANE bought 700 shares of the business’s stock. A total of $11,551 was incurred on buying the stock at an average price of $16.50. A total of 30.10% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $11.20 and a high of $23.79.
The net profit margin was 0.28% and return on equity was 2.80% for OSCR. The company reported revenue of $2.39 billion for the quarter, compared to $1.43 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 67.11 percent.
